DUBLIN--(BUSINESS WIRE)--Research and Markets (http://www.researchandmarkets.com/research/zwmh4h/smoking_cessation) has announced the addition of the "Smoking Cessation and Nicotine De-addiction Products Market - Global Industry Analysis, Size, Share, Growth, Trends and Forecast, 2013 - 2019" report to their offering.
Electronic cigarettes is the largest and the fastest growing segment in the smoking cessation market.
Smoking cessation or nicotine de-addiction can be achieved by various modes such as nicotine replacement products, e-cigarettes, anti-depressants and nicotine receptor agonists such as Zyban (bupropion), and Chantix/Champix (varenicline). Smoking de-addiction is also possible with or without assistance of healthcare professionals. The smoking cessation products market has been extensively analyzed on the basis of factors such as the products popularly used, success rate, and geographical reach.
This report studies the global smoking cessation and nicotine de-addiction products market from the perspective of various product types available in the market. These include nicotine replacement therapy (NRT) products, drug therapy and e-cigarettes. The NRT products market is broadly segmented into nicotine containing gums, transdermal patches, lozenges, sublingual tablets, sprays and nasal inhalers. The prominently used brands for smoking cessation are Zyban and Chantix/Champix which comprise the drug therapy segment of the market. Geographically, the market is analyzed for four major regions, namely North America, Europe, Asia Pacific and Rest of the World (RoW).
Each of the segments have been analyzed on the basis of their current and future market size for the period 2011 to 2019, in terms of revenue (USD million), considering 2011 and 2012 as the base years. The compounded annual growth rate (% CAGR) for each market segment has been provided for the forecast period 2013 to 2019 along with the estimations of market size.
A competitive landscape, mapping all the market players and their respective shares in the smoking cessation and nicotine de-addiction products market for 2012 are provided in this report. Some of the major players profiled for NRT products include Johnson & Johnson, GSK, Pfizer, Takeda Pharmaceuticals Co. Ltd., Cipla, and Revolymer PLC. GSK and Pfizer lead the market for drug therapy while the key players profiled for e-cigarettes market include VMR products, and NJOY.
Key Topics Covered:
- Introduction
- Executive Summary
- Global Smoking Cessation and Nicotine De-addiction Market Overview
- Global Smoking Cessation and Nicotine De-addiction Products Market, by Product Type
- Global Smoking Cessation and Nicotine De-addiction Products Market, by Geography
- Competitive Landscape
- Recommendations
- Company Profiles
- Cipla Ltd.
- GlaxoSmithKline, Inc.
- Imperial Tobacco Company of India (ITC Ltd).
- McNeil AB
- NJOY, Inc.
- Novartis International AG
- Pfizer, Inc.
- Revolymer PLC
- Takeda Pharmaceutical Co. Ltd.
- VMR Products LLC
For more information visit http://www.researchandmarkets.com/research/zwmh4h/smoking_cessation
